A biopharmaceutical company focused on the discovery, development and commercialization of therapeutics for the treatment of serious and rare diseases
| CAGE Code | 623P9 |
|---|---|
| Company Operating Status | Active |
| Full Address | 126 East Lincoln Avenue P.O. Box 2000 Rahway, NJ 07065 USA |
| Legal Entity Identifier | 529900TQRID2UY164805 |
| Stock Symbol | XLRN |
| Ticker Symbol | XLRN |
| Wellfound ID | acceleron-pharma |
| Wikidata ID | Q16824238 |